Sector: Healthcare|Industry: Medical Instruments & Supplies|Market Cap: $8.38B|Employees: 14K
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety, and reduce total procedural costs. The company primarily designs, develops, manufactures, and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex markets and sells its products worldwide through a combination of its direct sales force and distributors. The company's major manufacturing operations are located in the Czech Republic, Malaysia, Mexico, and the United States.
Teleflex is focused on achieving consistent, sustainable, and profitable growth and improving financial performance by increasing market share and improving operating efficiencies.
Mr. Kelly has been the President and Chief Executive Officer since January 2018 and Chairman of the Board since May 2020. Mr. Powell has been the Executive Vice President and Chief Financial Officer since February 2013.
Teleflex's product categories include:
Teleflex operates through four segments:
The following shows the percentage of net revenues by reportable operating segment as a percentage of total consolidated net revenues for the year ended December 31, 2023: Americas (58%), OEM (11%), EMEA (20%), Asia (11%).
Teleflex's strategy is focused on achieving consistent, sustainable, and profitable growth and improving financial performance by increasing market share and improving operating efficiencies. Key strategic initiatives include:
Teleflex continues to execute its footprint realignment and other restructuring programs designed to improve efficiencies in manufacturing and distribution facilities and its sales and marketing and research and development organizations. The company also expects to continue to increase the size of its business through a combination of acquisitions and organic growth initiatives.
Teleflex operates in the highly competitive medical device industry, competing with a range of companies from small start-ups to large, established corporations. The company competes primarily on the basis of clinical superiority and innovative features that enhance patient benefit, product reliability, performance, customer and sales support, and cost-effectiveness. The medical device industry is characterized by extensive product research and development and rapid technological advances.
(Generated from latest 10-K filing)